SCHEMBL7370457

SCHEMBL7370457

COC(c1ccccc1)C(COCc1ccccc1)OC(=O)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.46
ALDH1A1 P00352 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
MGLL Q99685 1/20 0.40
KMT2A Q03164 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
LMNA P02545 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
AR P10275 1/20 0.38
BCL9 O00512 1/20 0.38
CTNNB1 P35222 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7370462 0.82 HTR2A (0.51) HTR2AALDH1A1SMN1; SMN2MGLLNPC1
SCHEMBL7418355 0.75 HTR2A (0.57) HTR2AALDH1A1SMN1; SMN2KMT2ANPC1
SCHEMBL29592309 0.74 HTR2A (0.62) HTR2AALDH1A1SMN1; SMN2KMT2ANPC1
SCHEMBL6443753 0.74 MGLL (0.54) HTR2AALDH1A1SMN1; SMN2MGLLKMT2A
SCHEMBL8818613 0.73 ALDH1A1 (0.52) HTR2AALDH1A1SMN1; SMN2MGLLKMT2A
SCHEMBL21570247 0.73 ALDH1A1 (0.52) HTR2AALDH1A1SMN1; SMN2MGLLKMT2A
SCHEMBL389680 0.73 ALDH1A1 (0.52) HTR2AALDH1A1SMN1; SMN2MGLLKMT2A
SCHEMBL1714950 0.73 HTR2A (0.70) HTR2AALDH1A1SMN1; SMN2KMT2ANPC1
SCHEMBL4644851 0.72 HTR2A (0.56) HTR2AALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8817429 0.72 ALDH1A1 (0.53) HTR2AALDH1A1SMN1; SMN2MGLLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5907068-A TRIFLUOROMETHYLSUBSTITUTED COMPOUND INCLUDED IN PEPTIDES ZENECA INC. (US) 1999-05-25 US disclosed
US-5726158-A INHIBITORS OF HUMAN LEUKOCYTE ELASTASE USEFUL IN TREATING TISSUE DEGENERATIVE DISEASES; TRIFLUOROMETHYL KETONE SUBSTITUTED DI-, TRI-, AND TETRA-PEPTIDE DERIVATIVES ZENECA INC. (US) 1998-03-10 US disclosed
US-5414132-A Peptide intermediates ZENECA INC. (US) 1995-05-09 US disclosed
US-5194588-A Inhibitors of human leukocyte elastase, di-, tri- and tetra-peptides ICI AMERICAS INC. (US) 1993-03-16 US disclosed
EP-0189305-B1 PEPTIDE DERIVATIVES ICI AMERICAS INC. (US) 1992-07-29 EP disclosed